|1.||Hsieh, Yih-Shou: 2 articles (06/2013 - 01/2008)|
|2.||Kuo, Dong-Yih: 2 articles (06/2013 - 01/2008)|
|3.||Aveyard, Paul: 2 articles (01/2012 - 01/2009)|
|4.||Hajek, Peter: 2 articles (01/2012 - 01/2009)|
|5.||McNeil, John J: 2 articles (01/2006 - 01/2005)|
|6.||Ioannides-Demos, Lisa L: 2 articles (01/2006 - 01/2005)|
|7.||Proietto, Joseph: 2 articles (01/2006 - 01/2005)|
|8.||Gil-Agustí, M: 2 articles (05/2001 - 04/2001)|
|9.||García-Alvarez-Coque, M C: 2 articles (05/2001 - 04/2001)|
|10.||Esteve-Romero, J: 2 articles (05/2001 - 04/2001)|
|1.||Weight Loss (Weight Reduction)
11/01/1999 - "The two phenylpropanolamine studies gave the same weight losses, but the dropouts were 37% at 8 weeks for free care vs. 11% for contingency contracting (p<0.001). "
01/01/1982 - "Three controlled trials of weight loss with phenylpropanolamine."
08/01/1999 - "Phenylpropanolamine is proven successful in weight loss. "
07/01/1992 - "Phenylpropanolamine (PPA), an over-the-counter drug, is used for weight reduction but its effectiveness is controversial. "
10/01/1990 - "The pharmacist has an important role in preventing misuse and abuse of phenylpropanolamine through counseling the patient about its appropriate, short-term (not exceeding 12 weeks) use in a comprehensive weight-reduction program. "
06/01/1990 - "It is concluded that phenylpropanolamine may help reduce weight gain associated with smoking abstinence and in this way may enhance smoking cessation efforts in certain individuals."
06/01/1990 - "This investigation evaluated the effect of phenylpropanolamine on the weight gain associated with 2 weeks of abstinence from smoking. "
05/01/1995 - "A prior report (Klesges et al. 1990) suggested that phenylpropanolamine (PPA) was successful in reducing the smoking withdrawal symptom of weight gain in a sample of women. "
01/01/2005 - "A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women."
01/01/1992 - "Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats."
|3.||Seasonal Allergic Rhinitis (Hay Fever)
11/01/1989 - "The efficacy of terfenadine in combination with phenylpropanolamine was assessed by comparison with terfenadine alone in a double-blind, parallel group study of 66 patients with nasal birch pollen allergy. "
11/01/1989 - "It is concluded that terfenadine combined with phenylpropanolamine gives better control of seasonal allergic rhinitis than terfenadine alone."
11/01/1989 - "Terfenadine with or without phenylpropanolamine in the treatment of seasonal allergic rhinitis."
05/01/1993 - "Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis."
03/01/1996 - "The efficacy and side effects of once-daily astemizole-D, a combination of 10 mg astemizole and 240 mg pseudoephedrine, were compared with those of twice-daily brompheniramine-D, a combination of 12 mg brompheniramine and 50 mg phenylpropanolamine (Lunerin), in 64 patients with seasonal allergic rhinitis caused by birch pollen. "
08/01/2005 - "Oral phenylpropanolamine is commonly used to treat congestion and obesity. "
07/01/1992 - "Effectiveness of phenylpropanolamine in the management of moderate obesity."
02/01/1989 - "A total of 837 healthy volunteers presenting with various degrees of obesity participated in a large-scale, double-blind, placebo-controlled evaluation of the subjective effects of phenylpropanolamine (PPA), with particular attention to measurement of the euphoriant or stimulant potential of therapeutic doses of the compound. "
04/01/2003 - "Inherent and induced physiological differences of low-fat and high-fat preferring animals are discussed as well as phenylpropanolamine's potential in combination drug therapy for the treatment of human hyperphagic obesity."
03/01/1993 - "These symptoms occurred after cessation of obesity drug therapy with norephedrine (250 mg/day) continuously over six years. "
07/01/1990 - "A double-blind randomized placebo-controlled study comparing the effect of 2-dose levels of phenylpropanolamine (PPA) for acute rhinitis was performed in 180 outpatients. "
12/01/2006 - "The aim of this placebo-controlled double-blind study was to evaluate the decongestive effect of phenylpropanolamine (PPA 50 mg) twice daily for seven days in 38 women with pregnancy rhinitis. "
01/01/1986 - "The effect of a topically administered alpha-adrenoceptor agonist (phenylpropanolamine) after allergen challenge was evaluated in a placebo-controlled double-blind crossover study in 10 subjects with allergic rhinitis in an asymptomatic period. "
05/01/1982 - "Efficacy of phenylephrine-phenylpropanolamine in the treatment of rhinitis."
11/01/1981 - "Allergic rhinitis patients were challenged with intranasal allergen aerosols after pretreatment with hydroxyzine and phenylpropanolamine, singly and in combination. "
|6.||Caffeine (No Doz)
|2.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)